PLPL Stock UPDATES Diamond Ranch Foods (PLPL) 0.3270 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Diamond Ranch Foods (PLPL) 0.3270 $PLPL

Plandai Biotechnology's Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial Conducted in South Africa
Marketwire - Wed Sep 10, 8:04AM CDT
Plandai Biotechnology (OTCQB: PLPL) recently released the preliminary results from its human clinical trial where the company's green tea extract, Phytofare(TM) Catechin Complex, was clinically tested and compared to a commercially available green tea extract. In the clinical trial, Plandai's Phytofare(TM) extract product showed greater bioavailability to participants than did the commercial extract by a factor of 10.

Plandaí Biotechnology, Inc. Announces Preliminary Results of Study Showing Phytofaretm Catechin Complex Having Ten Times The Greater Bioavailability Than Generic Green Tea Extracts
ACCESSWIRE - Thu Sep 04, 8:11AM CDT
Greater Bioavailability Allows the Body to Experience More of the Positive Health Benefits of the Green Tea

Plandaí Biotechnology, Inc. Provides Shareholder Update on Completion of the Company's Production Facility and Start of Commercial Production
ACCESSWIRE - Wed Aug 06, 8:25AM CDT
The Update Also Provides New Information on Studies Involving Plandaí Products, Including an Upcoming Phase II Human Clinical Trial

Planda Biotechnology, Inc. Provides Shareholder Update on Completion of the Companys Production Facility and Start of Commercial Production
eTeligis - Wed Aug 06, 8:11AM CDT
SEATTLE, WA, United States, via ETELIGIS INC., 08/06/2014 - - Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today provided an update to shareholders that covers topics including the completion and optimization of the company's state-of-the-art production facility in South Africa and the schedule for commencement of commercial production at the facility.

Plandai Biotechnology, Inc. Announces Support of ICCCO -- the World's First International Cannabis Trade Association
Marketwire - Mon Jul 07, 8:01AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced its support for the formation of the International Coalition of Cannabis Companies and Organizations (ICCCO), the world's first international cannabis trade association co-founded by Plandai director, Jamen Shively. ICCCO was recently formed to deliver on the demands of citizens worldwide: the creation and maintenance of a global cannabis industry, which enforces social responsibility, generates jobs and tax revenues, and ensures consistent standards.

OTC Stocks Daily Trading Focus: Neutra Corporation, Terra Tech Corp, Plandai Biotechnology, Inc. Nano Tech Entertainment, Inc. Techprecision Corp.
PR Newswire Europe - Thu Jul 03, 7:01AM CDT
LONDON, July 3, 2014 /PRNewswire/ --

FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product
Marketwire - Thu Jun 26, 8:02AM CDT
Plandai Biotechnology (OTCQB: PLPL) recently learned that it qualifies for an exemption that will allow the company to commence sales of its Phytofare(TM) Catechin Complex as a dietary supplement without the need to apply to the US Food and Drug Administration (FDA) for approval to market the product.

Plandai Biotechnology, Inc. Announces Phytofare(TM) Catechin Complex Shows Over Two Times the Level of Catechins Compared to Generic Extract
Marketwire - Tue Jun 24, 8:15AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has received test results from North-West University that indicate that Plandai's Phytofare(TM) Catechin Complex, which is derived from green tea phyto-nutrients, contains 2.2 times the amount of catechins by weight when compared to generic green tea extracts.

Plandai Biotechnology, Inc. Announces Phytofare(TM) Catechin Complex Can Be Used as a Dietary Supplement Without Prior FDA Notification or Approval
Marketwire - Wed Jun 18, 7:55AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has received a legal opinion from the noted law firm of Hyman, Phelps & McNamara, P.C., the largest dedicated food and drug legal firm in the country, in which it was determined that Plandai will not be required to apply to the US Food and Drug Administration for approval to market and sell its Phytofare(TM) Catechin Complex as a dietary supplement. This opinion paves the way for Plandai to immediately commence sales efforts in the United States.

Plandai Biotechnology, Inc. Commissions Stage 2 of Senteeko Phytofare Factory
Marketwire - Tue Apr 01, 8:03AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has completed and successfully optimized Stage 2 of its state-of-the-art production facility on the Senteeko Tea Estate in South Africa. Section 2 is the critical stage of the factory's operations as it is in this section that the hydrodynamic sheering process takes place.

Confidential LOI Executed for Unprecedented 'Marijuana Index Fund' - Possible Retracement as The Marijuana Index Dips to $17.95 - 175,000 Jobs Added in February Per US Department of Labor
ACCESSWIRE - Mon Mar 31, 8:09PM CDT
March 31, 2014 / The Marijuana Index - the first and only equity tracking index for marijuana stocks, cannabis stocks, and hemp stocks featuring dynamic financial content, charts, and centralized press for public companies - experienced several significant (positive) events during an otherwise turbulent month (beware the Ides of March, indeed).

Plandai Biotechnology "Waiver" Could Dramatically Expedite Medical Marijuana Research
Marketwire - Mon Mar 31, 8:04AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL) has a real opportunity to advance its medical marijuana research, and in doing so, it could be one of the first publicly traded companies in the cannabis industry to reach clinical trials with the drug. While laws in the US still prohibit the advancement of research using marijuana due to its Schedule 1 classification, Plandai's interest in using the drug to discover promising treatments may be about to come to fruition. The company may owe this unexpected opportunity to relationships it has formed on an entirely different continent.

Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts
Marketwire - Fri Mar 28, 8:01AM CDT
Last month Plandai Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare(TM) cannabis extract in medical and pharmaceutical marijuana applications. Plandai will produce the new Diego Pellicer Gold(TM) extracts in both capsules and cannabis oil (for vapor use) in Pheroid(TM) and non-Pheroid(TM) versions to appeal to the broadest range of medicinal consumers.

Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
Marketwire - Wed Mar 26, 8:04AM CDT
What may have been lost in Plandai Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging properties of Phytofare(TM), is that the "statistically significant" results are themselves extremely significant to the future of the company. First and foremost, the results delivered in this human trial using Plandai's Phytofare(TM) Catechin Complex show "proof of concept," and for investors, that proof should turn out to be no small thing when it comes to the future success of this company.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 193

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 131

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 104

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 88

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 115

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 95

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 123

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 94

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Choice Hotels International Advances with 500th Extended Stay Launch

Updated Category News Views 52

Major Growth for Choice Hotels International Choice Hotels International, Inc. (NYSE: CHH) is celebrating a significant milestone as it recently unveiled its 500th extended stay property. This landmark event marks a new chapter in its expansion journey, particularly with the launch of an Everhome Suites. This accomplishment highlights the steady growth and strategic...

Continue Reading
TWC Enterprises Limited to Optimize Shareholder Value Through Buyback

Updated Category News Views 163

TWC Enterprises Limited Launches New Share Buyback Initiative TWC Enterprises Limited (“TWC”) has made a significant announcement regarding its strategy for enhancing shareholder value. The Toronto Stock Exchange (TSX) has accepted TWC’s notice to initiate a normal course issuer bid, which allows the company to buy back shares through the TSX and other Canadian...

Continue Reading
Fluoropolymer Market Growth and Innovations Forecasted

Updated Category News Views 212

Fluoropolymer Market Overview The global fluoropolymer market is experiencing significant growth, anticipated to reach a remarkable valuation of USD 7.3 billion by the year 2034. This growth trajectory represents a compound annual growth rate (CAGR) of 5.2% from the previous valuation of USD 3.9 billion in 2023. The rising demand for fluoropolymers is largely attributed...

Continue Reading
Duluth Trading Company Enhances Customer Engagement with Listrak

Updated Category News Views 85

Duluth Trading Company's Innovations in Customer Communication Listrak's advanced technology will enhance cross-platform personalization for the esteemed lifestyle brand. Duluth Trading Company, a recognized name in the realm of men's and women's workwear, casual attire, and outdoor apparel, has taken a significant step towards enhancing its customer communication by...

Continue Reading
Genuine Parts Company Announces Exciting Quarterly Dividend

Updated Category News Views 105

Genuine Parts Company Announces Quarterly Dividend Genuine Parts Company (NYSE: GPC), a renowned global leader in the supply of automotive and industrial replacement parts, has made an exciting announcement regarding a quarterly dividend. This commitment to delivering value to their shareholders reflects the company's robust performance and ongoing growth. Dividend...

Continue Reading